메뉴 건너뛰기




Volumn 1, Issue 6, 2010, Pages 650-659

Therapeutic Targeting of Myc

Author keywords

10058 F4; ID proteins; Mad; Max

Indexed keywords


EID: 79952854742     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601910377494     Document Type: Article
Times cited : (132)

References (88)
  • 1
    • 84925307652 scopus 로고
    • Comparative therapeutic effects of radioactive and chemical agents in neoplastic diseases of the hemopoietic system
    • Brues AM, Jacobson LO. Comparative therapeutic effects of radioactive and chemical agents in neoplastic diseases of the hemopoietic system. Am J Roentgenol Radium Ther 1947;58:774-82.
    • (1947) Am J Roentgenol Radium Ther , vol.58 , pp. 774-782
    • Brues, AM1    Jacobson, LO.2
  • 2
    • 78651010566 scopus 로고
    • Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid
    • Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 1948;238:787-93.
    • (1948) N Engl J Med , vol.238 , pp. 787-793
    • Farber, S1    Diamond, LK.2
  • 3
    • 37049222627 scopus 로고
    • Endocrine control of prostatic cancer
    • Huggins C. Endocrine control of prostatic cancer. Science 1943;97:541-4.
    • (1943) Science , vol.97 , pp. 541-544
    • Huggins, C.1
  • 4
    • 50549191387 scopus 로고
    • Tumor inhibitory effect of L-asparaginase from Escherichia coli
    • Mashburn LT, Wriston JC Jr. Tumor inhibitory effect of L-asparaginase from Escherichia coli. Arch Biochem Biophys 1964;105:450-2.
    • (1964) Arch Biochem Biophys , vol.105 , pp. 450-452
    • Mashburn, LT1    Wriston, JC2
  • 5
    • 65649090993 scopus 로고    scopus 로고
    • BRAF signaling and targeted therapies in melanoma
    • Dhomen N, Marais R. BRAF signaling and targeted therapies in melanoma. Hematol Oncol Clin North Am 2009;23:529-45.
    • (2009) Hematol Oncol Clin North Am , vol.23 , pp. 529-545
    • Dhomen, N1    Marais, R.2
  • 6
    • 58149398623 scopus 로고    scopus 로고
    • Translation of the Philadelphia chromosome into therapy for CML
    • Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood 2008;112:4808-17.
    • (2008) Blood , vol.112 , pp. 4808-4817
    • Druker, BJ.1
  • 7
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-92.
    • (2001) N Engl J Med , vol.344 , pp. 783-792
    • Slamon, DJ1    Leyland-Jones, B2    Shak, S3
  • 8
    • 33847396951 scopus 로고    scopus 로고
    • Small molecule inhibitors of Stat3 signaling pathway
    • Deng J, Grande F, Neamati N. Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets 2007;7:91-107.
    • (2007) Curr Cancer Drug Targets , vol.7 , pp. 91-107
    • Deng, J1    Grande, F2    Neamati, N.3
  • 10
    • 58149401867 scopus 로고    scopus 로고
    • Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer
    • Patel S, Player MR. Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer. Expert Opin Investig Drugs 2008;17:1865-82.
    • (2008) Expert Opin Investig Drugs , vol.17 , pp. 1865-1882
    • Patel, S1    Player, MR.2
  • 11
    • 33745699614 scopus 로고    scopus 로고
    • Mutational analysis of MYC in common epithelial cancers and acute leukemias
    • Lee JW, Soung YH, Kim SY, et al. Mutational analysis of MYC in common epithelial cancers and acute leukemias. APMIS 2006;114:436-9.
    • (2006) APMIS , vol.114 , pp. 436-439
    • Lee, JW1    Soung, YH2    Kim, SY3
  • 12
    • 0033551374 scopus 로고    scopus 로고
    • MYC oncogenes and human neoplastic disease
    • Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999;18:3004-16.
    • (1999) Oncogene , vol.18 , pp. 3004-3016
    • Nesbit, CE1    Tersak, JM2    Prochownik, EV.3
  • 13
    • 0034653998 scopus 로고    scopus 로고
    • c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover
    • Bahram F, von der Lehr N, Cetinkaya C, Larsson LG. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 2000;95:2104-10.
    • (2000) Blood , vol.95 , pp. 2104-2110
    • Bahram, F1    von der Lehr, N2    Cetinkaya, C3    Larsson, LG.4
  • 14
    • 0027275755 scopus 로고
    • Point mutations in the c-Myc transactivation domain are common in Burkitt’s lymphoma and mouse plasmacytomas
    • Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I. Point mutations in the c-Myc transactivation domain are common in Burkitt’s lymphoma and mouse plasmacytomas. Nat Genet 1993;5:56-61.
    • (1993) Nat Genet , vol.5 , pp. 56-61
    • Bhatia, K1    Huppi, K2    Spangler, G3    Siwarski, D4    Iyer, R5    Magrath, I.6
  • 15
    • 0028305664 scopus 로고
    • Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas
    • Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D, Raffeld M. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res 1994;54:3383-6.
    • (1994) Cancer Res , vol.54 , pp. 3383-3386
    • Clark, HM1    Yano, T2    Otsuki, T3    Jaffe, ES4    Shibata, D5    Raffeld, M.6
  • 16
    • 0028115718 scopus 로고
    • Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo
    • Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 1994;9:59-70.
    • (1994) Oncogene , vol.9 , pp. 59-70
    • Pulverer, BJ1    Fisher, C2    Vousden, K3    Littlewood, T4    Evan, G5    Woodgett, JR.6
  • 17
    • 0027220503 scopus 로고
    • Clustered mutations in the second exon of the MYC gene in sporadic Burkitt’s lymphoma
    • Yano T, Sander CA, Clark HM, Dolezal MV, Jaffe ES, Raffeld M. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt’s lymphoma. Oncogene 1993;8:2741-8.
    • (1993) Oncogene , vol.8 , pp. 2741-2748
    • Yano, T1    Sander, CA2    Clark, HM3    Dolezal, MV4    Jaffe, ES5    Raffeld, M.6
  • 18
    • 0034059667 scopus 로고    scopus 로고
    • c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt’s lymphoma cells
    • Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt’s lymphoma cells. Mol Cell Biol 2000;20:2423-35.
    • (2000) Mol Cell Biol , vol.20 , pp. 2423-2435
    • Gregory, MA1    Hann, SR.2
  • 19
    • 67749122122 scopus 로고    scopus 로고
    • Targeting PI3K signalling in cancer: opportunities, challenges and limitations
    • Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009;9:550-62.
    • (2009) Nat Rev Cancer , vol.9 , pp. 550-562
    • Engelman, JA.1
  • 20
    • 77949366910 scopus 로고    scopus 로고
    • Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase
    • Kantarjian HM, Cortes J, La Rosee P, Hochhaus A. Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase. Cancer 2010;116:1419-30.
    • (2010) Cancer , vol.116 , pp. 1419-1430
    • Kantarjian, HM1    Cortes, J2    La Rosee, P3    Hochhaus, A.4
  • 23
    • 0842265178 scopus 로고    scopus 로고
    • Cancer treatment with kinase inhibitors: what have we learnt from imatinib?
    • Ross DM, Hughes TP. Cancer treatment with kinase inhibitors: what have we learnt from imatinib? Br J Cancer 2004;90:12-9.
    • (2004) Br J Cancer , vol.90 , pp. 12-19
    • Ross, DM1    Hughes, TP.2
  • 24
    • 35748985280 scopus 로고    scopus 로고
    • Protein kinase inhibitors: structural insights into selectivity
    • Thaimattam R, Banerjee R, Miglani R, Iqbal J. Protein kinase inhibitors: structural insights into selectivity. Curr Pharm Des 2007;13:2751-65.
    • (2007) Curr Pharm Des , vol.13 , pp. 2751-2765
    • Thaimattam, R1    Banerjee, R2    Miglani, R3    Iqbal, J.4
  • 25
    • 33748145149 scopus 로고    scopus 로고
    • Mechanism of transcriptional activation by the Myc oncoproteins
    • Cowling VH, Cole MD. Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 2006;16:242-52.
    • (2006) Semin Cancer Biol , vol.16 , pp. 242-252
    • Cowling, VH1    Cole, MD.2
  • 26
    • 0034130734 scopus 로고    scopus 로고
    • Structural chemistry and therapeutic intervention of protein-protein interactions in immune response, human immunodeficiency virus entry, and apoptosis
    • Huang Z. Structural chemistry and therapeutic intervention of protein-protein interactions in immune response, human immunodeficiency virus entry, and apoptosis. Pharmacol Ther 2000;86:201-15.
    • (2000) Pharmacol Ther , vol.86 , pp. 201-215
    • Huang, Z.1
  • 27
    • 0030028728 scopus 로고    scopus 로고
    • Principles of protein– protein interactions
    • Jones S, Thornton JM. Principles of protein– protein interactions. Proc Natl Acad Sci U S A 1996;93:13-20.
    • (1996) Proc Natl Acad Sci U S A , vol.93 , pp. 13-20
    • Jones, S1    Thornton, JM.2
  • 28
    • 0031993453 scopus 로고    scopus 로고
    • Inhibiting the assembly of protein–protein interfaces
    • Zutshi R, Brickner M, Chmielewski J. Inhibiting the assembly of protein–protein interfaces. Curr Opin Chem Biol 1998;2:62-6.
    • (1998) Curr Opin Chem Biol , vol.2 , pp. 62-66
    • Zutshi, R1    Brickner, M2    Chmielewski, J.3
  • 29
    • 41149113439 scopus 로고    scopus 로고
    • c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle
    • Wang H, Mannava S, Grachtchouk V, et al. c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 2008;27:1905-15.
    • (2008) Oncogene , vol.27 , pp. 1905-1915
    • Wang, H1    Mannava, S2    Grachtchouk, V3
  • 30
    • 0842303173 scopus 로고    scopus 로고
    • Reversibility of oncogene-induced cancer
    • Felsher DW. Reversibility of oncogene-induced cancer. Curr Opin Genet Dev 2004;14:37-42.
    • (2004) Curr Opin Genet Dev , vol.14 , pp. 37-42
    • Felsher, DW.1
  • 31
    • 0033180211 scopus 로고    scopus 로고
    • Reversible tumorigenesis by MYC in hematopoietic lineages
    • Felsher DW, Bishop JM. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 1999;4:199-207.
    • (1999) Mol Cell , vol.4 , pp. 199-207
    • Felsher, DW1    Bishop, JM.2
  • 32
    • 0037025201 scopus 로고    scopus 로고
    • Sustained loss of a neoplastic phenotype by brief inactivation of MYC
    • Jain M, Arvanitis C, Chu K, et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 2002;297:102-4.
    • (2002) Science , vol.297 , pp. 102-104
    • Jain, M1    Arvanitis, C2    Chu, K3
  • 33
    • 10944258521 scopus 로고    scopus 로고
    • Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation
    • Boxer RB, Jang JW, Sintasath L, Chodosh LA. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 2004;6:577-86.
    • (2004) Cancer Cell , vol.6 , pp. 577-586
    • Boxer, RB1    Jang, JW2    Sintasath, L3    Chodosh, LA.4
  • 34
    • 0038107350 scopus 로고    scopus 로고
    • Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations
    • Karlsson A, Giuriato S, Tang F, Fung-Weier J, Levan G, Felsher DW. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. Blood 2003;101: 2797-803.
    • (2003) Blood , vol.101 , pp. 2797-2803
    • Karlsson, A1    Giuriato, S2    Tang, F3    Fung-Weier, J4    Levan, G5    Felsher, DW.6
  • 35
    • 53349103292 scopus 로고    scopus 로고
    • Modelling Myc inhibition as a cancer therapy
    • Soucek L, Whitfield J, Martins CP, et al. Modelling Myc inhibition as a cancer therapy. Nature 2008;455:679-83.
    • (2008) Nature , vol.455 , pp. 679-683
    • Soucek, L1    Whitfield, J2    Martins, CP3
  • 36
    • 0035118130 scopus 로고    scopus 로고
    • A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation
    • Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S, Sedivy JM. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. Cancer Res 2001;61:1178-86.
    • (2001) Cancer Res , vol.61 , pp. 1178-1186
    • Bazarov, AV1    Adachi, S2    Li, SF3    Mateyak, MK4    Wei, S5    Sedivy, JM.6
  • 37
    • 34748867198 scopus 로고    scopus 로고
    • Improved low molecular weight Myc–Max inhibitors
    • Wang H, Hammoudeh DI, Follis AV, et al. Improved low molecular weight Myc–Max inhibitors. Mol Cancer Ther 2007;6:2399-408.
    • (2007) Mol Cancer Ther , vol.6 , pp. 2399-2408
    • Wang, H1    Hammoudeh, DI2    Follis, AV3
  • 38
    • 0027240083 scopus 로고
    • The ornithine decarboxylase gene is a transcriptional target of c-Myc
    • Bello-Fernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A 1993;90:7804-8.
    • (1993) Proc Natl Acad Sci U S A , vol.90 , pp. 7804-7808
    • Bello-Fernandez, C1    Packham, G2    Cleveland, JL.3
  • 39
    • 0025167156 scopus 로고
    • The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation
    • Smith MJ, Charron-Prochownik DC, Prochownik EV. The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation. Mol Cell Biol 1990;10:5333-9.
    • (1990) Mol Cell Biol , vol.10 , pp. 5333-5339
    • Smith, MJ1    Charron-Prochownik, DC2    Prochownik, EV.3
  • 40
    • 0142057146 scopus 로고    scopus 로고
    • Low molecular weight inhibitors of Myc–Max interaction and function
    • Yin X, Giap C, Lazo JS, Prochownik EV. Low molecular weight inhibitors of Myc–Max interaction and function. Oncogene 2003;22:6151-9.
    • (2003) Oncogene , vol.22 , pp. 6151-6159
    • Yin, X1    Giap, C2    Lazo, JS3    Prochownik, EV.4
  • 41
    • 0028916599 scopus 로고
    • A hot spot of binding energy in a hormone-receptor interface
    • Clackson T, Wells JA. A hot spot of binding energy in a hormone-receptor interface. Science 1995;267:383-6.
    • (1995) Science , vol.267 , pp. 383-386
    • Clackson, T1    Wells, JA.2
  • 42
    • 20444486559 scopus 로고    scopus 로고
    • An inhibitor of Bcl-2 family proteins induces regression of solid tumours
    • Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005;435:677-81.
    • (2005) Nature , vol.435 , pp. 677-681
    • Oltersdorf, T1    Elmore, SW2    Shoemaker, AR3
  • 43
    • 67649362253 scopus 로고    scopus 로고
    • Regulated cell death pathways: new twists in modulation of BCL2 family function
    • Sasi N, Hwang M, Jaboin J, Csiki I, Lu B. Regulated cell death pathways: new twists in modulation of BCL2 family function. Mol Cancer Ther 2009;8:1421-9.
    • (2009) Mol Cancer Ther , vol.8 , pp. 1421-1429
    • Sasi, N1    Hwang, M2    Jaboin, J3    Csiki, I4    Lu, B.5
  • 44
    • 0037133575 scopus 로고    scopus 로고
    • Smallmolecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts
    • Berg T, Cohen SB, Desharnais J, et al. Smallmolecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc Natl Acad Sci U S A 2002;99:3830-5.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 3830-3835
    • Berg, T1    Cohen, SB2    Desharnais, J3
  • 45
    • 42149091567 scopus 로고    scopus 로고
    • Selective inhibition of c-Myc/Max dimerization by a pyrazolo[1,5-a]pyrimidine
    • Kiessling A, Wiesinger R, Sperl B, Berg T. Selective inhibition of c-Myc/Max dimerization by a pyrazolo[1,5-a]pyrimidine. ChemMedChem 2007;2:627-30.
    • (2007) ChemMedChem , vol.2 , pp. 627-630
    • Kiessling, A1    Wiesinger, R2    Sperl, B3    Berg, T.4
  • 46
    • 33746239002 scopus 로고    scopus 로고
    • Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules
    • Kiessling A, Sperl B, Hollis A, Eick D, Berg T. Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules. Chem Biol 2006;13:745-51.
    • (2006) Chem Biol , vol.13 , pp. 745-751
    • Kiessling, A1    Sperl, B2    Hollis, A3    Eick, D4    Berg, T.5
  • 47
    • 0035984722 scopus 로고    scopus 로고
    • Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions
    • Galarneau A, Primeau M, Trudeau LE, Michnick SW. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Nat Biotechnol 2002;20:619-22.
    • (2002) Nat Biotechnol , vol.20 , pp. 619-622
    • Galarneau, A1    Primeau, M2    Trudeau, LE3    Michnick, SW.4
  • 48
    • 0037133629 scopus 로고    scopus 로고
    • Protein-protein interactions monitored in mammalian cells via complementation of betalactamase enzyme fragments
    • Wehrman T, Kleaveland B, Her JH, Balint RF, Blau HM. Protein-protein interactions monitored in mammalian cells via complementation of betalactamase enzyme fragments. Proc Natl Acad Sci U S A 2002;99:3469-74.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 3469-3474
    • Wehrman, T1    Kleaveland, B2    Her, JH3    Balint, RF4    Blau, HM.5
  • 49
    • 34748851858 scopus 로고    scopus 로고
    • Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors
    • Lee HK, Brown SJ, Rosen H, Tobias PS. Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors. Mol Pharmacol 2007;72:868-75.
    • (2007) Mol Pharmacol , vol.72 , pp. 868-875
    • Lee, HK1    Brown, SJ2    Rosen, H3    Tobias, PS.4
  • 50
    • 0343550320 scopus 로고    scopus 로고
    • Two comparisons of the performance of positional scanning and deletion synthesis for the identification of active constituents in mixture combinatorial libraries
    • Boger DL, Lee JK, Goldberg J, Jin Q. Two comparisons of the performance of positional scanning and deletion synthesis for the identification of active constituents in mixture combinatorial libraries. J Org Chem 2000;65:1467-74.
    • (2000) J Org Chem , vol.65 , pp. 1467-1474
    • Boger, DL1    Lee, JK2    Goldberg, J3    Jin, Q.4
  • 51
    • 33644762865 scopus 로고    scopus 로고
    • A credit-card library approach for disrupting protein-protein interactions
    • Xu Y, Shi J, Yamamoto N, Moss JA, Vogt PK, Janda KD. A credit-card library approach for disrupting protein-protein interactions. Bioorg Med Chem 2006;14:2660-73.
    • (2006) Bioorg Med Chem , vol.14 , pp. 2660-2673
    • Xu, Y1    Shi, J2    Yamamoto, N3    Moss, JA4    Vogt, PK5    Janda, KD.6
  • 52
    • 40249102008 scopus 로고    scopus 로고
    • Disruption of the MYC transcriptional function by a smallmolecule antagonist of MYC/MAX dimerization
    • Lu X, Vogt PK, Boger DL, Lunec J. Disruption of the MYC transcriptional function by a smallmolecule antagonist of MYC/MAX dimerization. Oncol Rep 2008;19:825-30.
    • (2008) Oncol Rep , vol.19 , pp. 825-830
    • Lu, X1    Vogt, PK2    Boger, DL3    Lunec, J.4
  • 53
    • 0035912763 scopus 로고    scopus 로고
    • Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
    • Bowman T, Broome MA, Sinibaldi D, et al. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci U S A 2001;98:7319-24.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 7319-7324
    • Bowman, T1    Broome, MA2    Sinibaldi, D3
  • 54
    • 0030849451 scopus 로고    scopus 로고
    • Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination
    • Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 1997;8:1039-48.
    • (1997) Cell Growth Differ , vol.8 , pp. 1039-1048
    • Mateyak, MK1    Obaya, AJ2    Adachi, S3    Sedivy, JM.4
  • 55
    • 56049097680 scopus 로고    scopus 로고
    • Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules
    • Follis AV, Hammoudeh DI, Wang H, Prochownik EV, Metallo SJ. Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules. Chem Biol 2008;15:1149-55.
    • (2008) Chem Biol , vol.15 , pp. 1149-1155
    • Follis, AV1    Hammoudeh, DI2    Wang, H3    Prochownik, EV4    Metallo, SJ.5
  • 56
    • 67650523478 scopus 로고    scopus 로고
    • Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc
    • Hammoudeh DI, Follis AV, Prochownik EV, Metallo SJ. Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc. J Am Chem Soc 2009;131:7390-401.
    • (2009) J Am Chem Soc , vol.131 , pp. 7390-7401
    • Hammoudeh, DI1    Follis, AV2    Prochownik, EV3    Metallo, SJ.4
  • 58
    • 33947580381 scopus 로고    scopus 로고
    • A marriage made in torsional space: using GALAHAD models to drive pharmacophore multiplet searches
    • Shepphird JK, Clark RD. A marriage made in torsional space: using GALAHAD models to drive pharmacophore multiplet searches. J Comput Aided Mol Des 2006;20:763-71.
    • (2006) J Comput Aided Mol Des , vol.20 , pp. 763-771
    • Shepphird, JK1    Clark, RD.2
  • 59
    • 13844312649 scopus 로고    scopus 로고
    • ZINC: a free database of commercially available compounds for virtual screening
    • Irwin JJ, Shoichet BK. ZINC: a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005;45:177-82.
    • (2005) J Chem Inf Model , vol.45 , pp. 177-182
    • Irwin, JJ1    Shoichet, BK.2
  • 62
    • 42049098451 scopus 로고    scopus 로고
    • Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions
    • Liu J, Begley D, Mitchell DD, Verlinde CL, Varani G, Fan E. Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions. Chem Biol Drug Des 2008;71:408-19.
    • (2008) Chem Biol Drug Des , vol.71 , pp. 408-419
    • Liu, J1    Begley, D2    Mitchell, DD3    Verlinde, CL4    Varani, G5    Fan, E.6
  • 63
    • 0035853279 scopus 로고    scopus 로고
    • Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc
    • Fieber W, Schneider ML, Matt T, Krautler B, Konrat R, Bister K. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc. J Mol Biol 2001;307:1395-410.
    • (2001) J Mol Biol , vol.307 , pp. 1395-1410
    • Fieber, W1    Schneider, ML2    Matt, T3    Krautler, B4    Konrat, R5    Bister, K.6
  • 64
    • 0037462459 scopus 로고    scopus 로고
    • X-ray structures of Myc– Max and Mad-Max recognizing DNA: molecular bases of regulation by proto-oncogenic transcription factors
    • Nair SK, Burley SK. X-ray structures of Myc– Max and Mad-Max recognizing DNA: molecular bases of regulation by proto-oncogenic transcription factors. Cell 2003;112:193-205.
    • (2003) Cell , vol.112 , pp. 193-205
    • Nair, SK1    Burley, SK.2
  • 65
    • 25144472591 scopus 로고    scopus 로고
    • Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling
    • Uversky VN, Oldfield CJ, Dunker AK. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit 2005;18:343-84.
    • (2005) J Mol Recognit , vol.18 , pp. 343-384
    • Uversky, VN1    Oldfield, CJ2    Dunker, AK.3
  • 66
    • 77949762977 scopus 로고    scopus 로고
    • A comprehensive resource of interacting protein regions for refining human transcription factor networks
    • Miyamoto-Sato E, Fujimori S, Ishizaka M, et al. A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One 2010;5:e9289.
    • (2010) PLoS One , vol.5 , pp. e9289
    • Miyamoto-Sato, E1    Fujimori, S2    Ishizaka, M3
  • 67
    • 77249105931 scopus 로고    scopus 로고
    • Protein intrinsic disorder and oligomericity in cell signaling
    • Sigalov AB. Protein intrinsic disorder and oligomericity in cell signaling. Mol Biosyst 2010;6:451-61.
    • (2010) Mol Biosyst , vol.6 , pp. 451-461
    • Sigalov, AB.1
  • 68
    • 58849157916 scopus 로고    scopus 로고
    • Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-4ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
    • Guo J, Parise RA, Joseph E, et al. Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-4ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice. Cancer Chemother Pharmacol 2009;63:615-25.
    • (2009) Cancer Chemother Pharmacol , vol.63 , pp. 615-625
    • Guo, J1    Parise, RA2    Joseph, E3
  • 69
    • 77749270618 scopus 로고    scopus 로고
    • Molecular basis of different outcomes for drug-eluting stents that release sirolimus or tacrolimus
    • Giordano A. Molecular basis of different outcomes for drug-eluting stents that release sirolimus or tacrolimus. Curr Opin Drug Discov Devel 2010;13:159-68.
    • (2010) Curr Opin Drug Discov Devel , vol.13 , pp. 159-168
    • Giordano, A.1
  • 70
    • 72049114146 scopus 로고    scopus 로고
    • Meta-analysis of five randomized clinical trials comparing sirolimusversus paclitaxel-eluting stents in patients with diabetes mellitus
    • Zhang F, Dong L, Ge J. Meta-analysis of five randomized clinical trials comparing sirolimusversus paclitaxel-eluting stents in patients with diabetes mellitus. Am J Cardiol 2010;105:64-8.
    • (2010) Am J Cardiol , vol.105 , pp. 64-68
    • Zhang, F1    Dong, L2    Ge, J.3
  • 71
    • 33744488782 scopus 로고    scopus 로고
    • Rat carotid arteriotomy: c-myc is involved in negative remodelling and apoptosis
    • De Feo M, Forte A, Onorati F, et al. Rat carotid arteriotomy: c-myc is involved in negative remodelling and apoptosis. J Cardiovasc Med (Hagerstown) 2006;7:61-7.
    • (2006) J Cardiovasc Med (Hagerstown) , vol.7 , pp. 61-67
    • De Feo, M1    Forte, A2    Onorati, F3
  • 72
    • 20644469260 scopus 로고    scopus 로고
    • c-Myc antisense oligonucleotides preserve smooth muscle differentiation and reduce negative remodelling following rat carotid arteriotomy
    • Forte A, Galderisi U, De Feo M, et al. c-Myc antisense oligonucleotides preserve smooth muscle differentiation and reduce negative remodelling following rat carotid arteriotomy. J Vasc Res 2005;42:214-25.
    • (2005) J Vasc Res , vol.42 , pp. 214-225
    • Forte, A1    Galderisi, U2    De Feo, M3
  • 73
    • 12244259715 scopus 로고    scopus 로고
    • Antisense therapy for restenosis following percutaneous coronary intervention
    • Kipshidze N, Tsapenko M, Iversen P, Burger D. Antisense therapy for restenosis following percutaneous coronary intervention. Expert Opin Biol Ther 2005;5:79-89.
    • (2005) Expert Opin Biol Ther , vol.5 , pp. 79-89
    • Kipshidze, N1    Tsapenko, M2    Iversen, P3    Burger, D.4
  • 74
    • 38449100932 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor therapy for ocular neovascular disease
    • Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 2007;18:502-8.
    • (2007) Curr Opin Ophthalmol , vol.18 , pp. 502-508
    • Andreoli, CM1    Miller, JW.2
  • 75
    • 34547119296 scopus 로고    scopus 로고
    • Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema
    • Emerson MV, Lauer AK. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. BioDrugs 2007;21:245-57.
    • (2007) BioDrugs , vol.21 , pp. 245-257
    • Emerson, MV1    Lauer, AK.2
  • 76
    • 65549159481 scopus 로고    scopus 로고
    • Anti-angiogenic drugs as an adjunctive therapy in the surgical treatment of diabetic retinopathy
    • Figueroa MS, Contreras I, Noval S. Anti-angiogenic drugs as an adjunctive therapy in the surgical treatment of diabetic retinopathy. Curr Diabetes Rev 2009;5:52-6.
    • (2009) Curr Diabetes Rev , vol.5 , pp. 52-56
    • Figueroa, MS1    Contreras, I2    Noval, S.3
  • 77
    • 0025763419 scopus 로고
    • Max: a helixloop-helix zipper protein that forms a sequencespecific DNA-binding complex with Myc
    • Blackwood EM, Eisenman RN. Max: a helixloop-helix zipper protein that forms a sequencespecific DNA-binding complex with Myc. Science 1991;251:1211-7.
    • (1991) Science , vol.251 , pp. 1211-1217
    • Blackwood, EM1    Eisenman, RN.2
  • 79
    • 0032554768 scopus 로고    scopus 로고
    • Lack of transcriptional repression by max homodimers
    • Yin X, Grove L, Prochownik EV. Lack of transcriptional repression by max homodimers. Oncogene 1998;16:2629-37.
    • (1998) Oncogene , vol.16 , pp. 2629-2637
    • Yin, X1    Grove, L2    Prochownik, EV.3
  • 80
    • 0028937378 scopus 로고
    • Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice
    • Lindeman GJ, Harris AW, Bath ML, Eisenman RN, Adams JM. Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice. Oncogene 1995;10:1013-7.
    • (1995) Oncogene , vol.10 , pp. 1013-1017
    • Lindeman, GJ1    Harris, AW2    Bath, ML3    Eisenman, RN4    Adams, JM.5
  • 81
    • 0027175983 scopus 로고
    • Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells
    • Cogliati T, Dunn BK, Bar-Ner M, Cultraro CM, Segal S. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells. Oncogene 1993;8:1263-8.
    • (1993) Oncogene , vol.8 , pp. 1263-1268
    • Cogliati, T1    Dunn, BK2    Bar-Ner, M3    Cultraro, CM4    Segal, S.5
  • 82
    • 0027081907 scopus 로고
    • Transcriptional activities of the Myc and Max proteins in mammalian cells
    • Kretzner L, Blackwood EM, Eisenman RN. Transcriptional activities of the Myc and Max proteins in mammalian cells. Curr Top Microbiol Immunol 1992;182:435-43.
    • (1992) Curr Top Microbiol Immunol , vol.182 , pp. 435-443
    • Kretzner, L1    Blackwood, EM2    Eisenman, RN.3
  • 83
    • 11644261806 scopus 로고    scopus 로고
    • Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function
    • Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998;19:1639-62.
    • (1998) J Comput Chem , vol.19 , pp. 1639-1662
    • Morris, GM1    Goodsell, DS2    Halliday, RS3
  • 85
    • 11144229113 scopus 로고    scopus 로고
    • Virtual screening of human 5-aminoimidazole4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors
    • Li C, Xu L, Wolan DW, Wilson IA, Olson AJ. Virtual screening of human 5-aminoimidazole4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors. J Med Chem 2004;47:6681-90.
    • (2004) J Med Chem , vol.47 , pp. 6681-6690
    • Li, C1    Xu, L2    Wolan, DW3    Wilson, IA4    Olson, AJ.5
  • 86
    • 27744552355 scopus 로고    scopus 로고
    • Discovery of acetylcholinesterase peripheral anionic site ligands through computational refinement of a directed library
    • Dickerson TJ, Beuscher AET, Rogers CJ, et al. Discovery of acetylcholinesterase peripheral anionic site ligands through computational refinement of a directed library. Biochemistry 2005;44:14845-53.
    • (2005) Biochemistry , vol.44 , pp. 14845-14853
    • Dickerson, TJ1    Beuscher, AET2    Rogers, CJ3
  • 87
    • 33644869304 scopus 로고    scopus 로고
    • Discovery of protein phosphatase 2C inhibitors by virtual screening
    • Rogers JP, Beuscher AET, Flajolet M, et al. Discovery of protein phosphatase 2C inhibitors by virtual screening. J Med Chem 2006;49:1658-67.
    • (2006) J Med Chem , vol.49 , pp. 1658-1667
    • Rogers, JP1    Beuscher, AET2    Flajolet, M3
  • 88
    • 64349094802 scopus 로고    scopus 로고
    • Discovery of novel myc-max heterodimer disruptors with a three-dimensional pharmacophore model
    • Mustata G, Follis AV, Hammoudeh DI, et al. Discovery of novel myc-max heterodimer disruptors with a three-dimensional pharmacophore model. J Med Chem 2009;52:1247-50.
    • (2009) J Med Chem , vol.52 , pp. 1247-1250
    • Mustata, G1    Follis, AV2    Hammoudeh, DI3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.